Journal
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
Volume 47, Issue 7, Pages 745-750Publisher
INFORMA HEALTHCARE
DOI: 10.3109/00365521.2012.679681
Keywords
children; Crohn's disease; steroid; ulcerative colitis
Categories
Funding
- Emil Aaltonen Foundation
Ask authors/readers for more resources
Children with moderate to severe inflammatory bowel disease (IBD) are treated with systemic glucocorticoids (GCs). The majority of the patients respond to the given treatment; however, steroid resistance and dependency are significant clinical problems. Also therapy-related side effects limit the use of GCs in the control of active inflammation. This review summarizes recent knowledge of GC treatment in pediatric patients with IBD.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available